Intrathecal baclofen in children with spastic cerebral palsy: A double-blind, randomized, placebo-controlled, dose-finding study

Developmental Medicine and Child Neurology

Volumn 49, Issue 9, 2007, Pages 654-659

  Hoving, Marjanke A ^a   van Raak, Elisabeth P M ^a   Spincemaille, Geert H J J ^a   Palmans, Liesbeth J ^a   Sleypen, Frans A M ^b   Vles, Johan S H ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Child Rehab Center Franciscusoord   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; CEFAZOLIN; PLACEBO;

ADOLESCENT; ARTICLE; BOLUS INJECTION; CEREBRAL PALSY; CEREBROSPINAL FLUID PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSKINESIA; FEMALE; HUMAN; LETHARGY; MALE; MOTOR PERFORMANCE; MUSCLE HYPOTONIA; MUSCLE TONE; MYALGIA; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SIDE EFFECT; SPASTICITY; SWEATING; SYMPTOM; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

ADOLESCENT; BACLOFEN; CEREBRAL PALSY; CHILD; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INJECTIONS, SPINAL; MALE; MUSCLE RELAXANTS, CENTRAL; MUSCLE SPASTICITY; PATIENT SELECTION; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 34548236931     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/j.1469-8749.2007.00654.x     Document Type: Article

References (32)

1. Surman G, Bonellie S, Chalmers J, Colver A, Dolk H, Hemming K, King A, Kurinczuk JJ, Parkes J, Platt MJ. (2006) UKCP: A collaborative network of cerebral palsy registers in the United Kingdom. J Public Health (Oxf) 28: 148-156.
2. Gilmartin R, Bruce D, Storrs BB, Abbott R, Krach L, Ward J, Bloom K, Brooks WH, Johnson DL, Madsen JR, et al. (2000) Intrathecal baclofen for management of spastic cerebral palsy: Multicenter trial. J Child Neurol 15: 71-77.
3. Albright AL, Gilmartin R, Swift D, Krach LE, Ivanhoe CB, McLaughlin JF. (2003) Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin. J Neurosurg 98: 291-295.
4. Campbell WM, Ferrel A, McLaughlin JF, Grant GA, Loeser JD, Graubert C, Bjornson K. (2002) Long-term safety and efficacy of continuous intrathecal baclofen. Dev Med Child Neurol 44: 660-665.
5. Malcangio M, Bowery NG. (1996) GABA and its receptors in the spinal cord. Trends Pharmacol Sci 17: 457-462.
6. Kroin JS. (1992) Intrathecal drug administration. Present use and future trends. Clin Pharmacokinet 22: 319-326.
7. Penn RD, Kroin JS. (1985) Continuous intrathecal baclofen for severe spasticity. Lancet ii: 125-127.
8. Dralle D, Muller H, Zierski J, Klug N. (1985) Intrathecal baclofen for spasticity. Lancet ii: 1003.
9. Butler C, Campbell S. (2000) Evidence of the effects of intrathecal baclofen for spastic and dystonic cerebral palsy. AACPDM Treatment Outcomes Committee Review Panel. Dev Med Child Neurol 42: 634-645.
10. Albright AL. (1996) Intrathecal baclofen in cerebral palsy movement disorders. J Child Neurol 11 (Suppl. 1): S29-S35.
11. Van Schaeybroeck P, Nuttin B, Lagae L, Schrijvers E, Borghgraef C, Feys P. (2000) Intrathecal baclofen for intractable cerebral spasticity: A prospective placebo-controlled, double-blind study. Neurosurgery 46: 603-609.
12. Ashworth B. (1964) Preliminary trial of carisoprodol in multiple sclerosis. Practitioner 192: 540-542.
13. Damiano DL, Quinlivan JM, Owen BF, Payne P, Nelson KC, Abel MF. (2002) What does the Ashworth scale really measure and are instrumented measures more valid and precise? Dev Med Child Neurol 44: 112-118.
14. Pandyan AD, Johnson GR, Price CI, Curless RH, Barnes M P, Rodgers H. (1999) A review of the properties and limitations of the Ashworth and modified Ashworth Scales as measures of spasticity. Clin Rehabil 13: 373-383.
15. Chapman CR, Casey KL, Dubner R, Foley KM, Gracely RH, Reading AE. (1985) Pain measurement: An overview. Pain 22: 1-31.
16. Wallenstein SL, Heidrich G, Kaiko R, Houde R W. (1980) Clinical evaluation of mild analgesics: The measurement of clinical pain. Br J Clin Pharmacol 10 (Suppl. 2): 319S-327S.
17. Tyler DC, Tu A, Douthit J, Chapman CR. (1993) Toward validation of pain measurement tools for children: A pilot study. Pain 52: 301-309.
18. Singer AJ, Thode HC. (1998) Determination of the minimal clinically significant difference on a patient visual analog satisfaction scale. Acad Emerg Med 5: 1007-1011.
19. Aitken RC. (1969) Measurement of feelings using visual analogue scales. Proc R Soc Med 62: 989-993.
20. Guyatt G, Townsend M, Berman B, Keller JL. (1987) A comparison of Likert and visual analogue scales for measuring change in function. J Chronic Dis 40: 1129-1133.
21. Jaeschke R, Singer J, Guyatt G. (1990) A comparison of seven-point and visual analogue scales. Control Clin Trials 11: 43-51.
22. Bergsneider M. (2001) Evolving concepts of cerebrospinal fluid physiology. Neurosurg Clin N Am 12: 631-638.
23. Portella G, Cormio M, Citerio G, Contant C, Kiening K, Enblad P, Piper I. (2005) Continuous cerebral compliance monitoring in severe head injury: Its relationship with intracranial pressure and cerebral perfusion pressure. Acta Neurochir (Wien) 147: 707-713.
24. Albright AL, Ferson S, Carlos S. (2005) Occult hydrocephalus in children with cerebral palsy. Neurosurgery 56: 93-96.
25. Sponheim S, Skraastad O, Helseth E, Due-Tonnesen B, Aamodt G, Breivik H. (2003) Effects of 0.5 and 1.0 MAC isoflurane, sevoflurane and desflurane on intracranial and cerebral perfusion pressures in children. Acta Anaesthesiol Scand 47: 932-938.
26. Murphy NA, Irwin MC, Hoff C. (2002) Intrathecal baclofen therapy in children with cerebral palsy: Efficacy and complications. Arch Phys Med Rehabil 83: 1721-1725.
27. Awaad Y, Tayem H, Munoz S, Ham S, Michon AM, Awaad R. (2003) Functional assessment following intrathecal baclofen therapy in children with spastic cerebral palsy. J Child Neurol 18: 26-34.
28. Vloeberghs M, Keetley R, Morton R. (2005) Intrathecal baclofen in the management of spasticity due to cerebral palsy. Pediatr Rehabil 8: 172-179.
29. Scheinberg A, O'Flaherty S, Chaseling R, Dexter M. (2001) Continuous intrathecal baclofen infusion for children with cerebral palsy: A pilot study. J Paediatr Child Health 37: 283-288.
30. Albright AL, Awaad Y, Muhonen M, Boydston WR, Gilmartin R, Krach LE, Turner M, Zidek KA, Wright E, Swift D, Bloom K. (2004) Performance and complications associated with the synchromed 10-ml infusion pump for intrathecal baclofen administration in children. J Neurosurg 101 (Suppl. 1): 64-88.
31. Armstrong R W, Steinbok P, Cochrane DD, Kube SD, Fife SE, Farrell K. (1997) Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin. J Neurosurg 87: 409-414.
32. Hoving MA, van Kranen-Mastenbroek VH, van Raak E P, Spincemaille GH, Hardy EL, Vles JS, On behalf of the Dutch Study Group on Child Spasticity. (2006) Placebo controlled utility and feasibility study of the H-reflex and flexor reflex in spastic children treated with intrathecal baclofen. Clin Neurophysiol 117: 1508-1517.